SCHEMBL17126978

SCHEMBL17126978

CCCCSC(C(=O)c1ccc(Oc2ccc3ccccc3c2)cc1)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CETP P11597 1/20 0.40
▸ PPARG P37231 2/20 0.40
▸ PPARA Q07869 2/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ HDAC3 O15379 2/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ MEN1 O00255 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.36
▸ SIRT1 Q96EB6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17127028 0.97 CETP (0.42) CETPPPARGPPARANPC1RAB9A
SCHEMBL17127026 0.90 HDAC3 (0.47) CETPPPARANPC1RAB9AHDAC3
SCHEMBL17127364 0.89 PPARG (0.40) PPARGPPARANPC1RAB9AHDAC3
SCHEMBL17127022 0.87 PTGS2 (0.38) PPARGPPARANPC1RAB9ACYP2C9
SCHEMBL17127336 0.86 HDAC3 (0.46) CETPPPARAHDAC3
SCHEMBL17126974 0.85 PARP10 (0.46) HDAC3HDAC1HDAC2MEN1KMT2A
SCHEMBL17126977 0.84 PARP10 (0.44) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL17127027 0.81 PARP10 (0.44) HDAC3HDAC1HDAC2MEN1KMT2A
SCHEMBL17127025 0.81 PARP10 (0.43) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL17127356 0.81 MEN1 (0.38) PPARGPPARANPC1RAB9AHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS CETP 2388/4885PPARG 3645/4885PPARA 2304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback